Transcripts iNtRON Biotechnology, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-06-10 pm EDT			5-day change	1st Jan Change
5,880 ^KRW	-1.18%		-5.62%	-33.03%

Mar. 13	INtRON Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 15	Intron Biotechnology, Inc. Announces New Drug Part Secures A Potent Anti-Cancer Candidate, PHAGERIA®, with Broad Antimicrobial Activity Against ETBF (Enterotoxigenic B. Fragilis), A Harmful Microbe Associated with Colorectal Cancer	CI

No results for this search